A board-approved strategy changes, but risk reporting still emphasizes the discontinued product line. What should be reviewed?

1. The prior strategy's approval signatures
2. A larger sample of only the discontinued line
3. Only the report's cover page
4. The risk universe, priorities, indicators, and reporting alignment